Gene · 51115
Papers3,244
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,244
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gold and silver nanoparticles in Alzheimer's and Parkinson's diagnostics and treatments. | Ibrain | 2023 | 37786760 | PubTator, text mining | PubMed |
| Dose-dependent binding behavior of anthraquinone derivative purpurin interacting with tau-derived peptide protofibril. | Phys Chem Chem Phys | 2023 | 37781899 | PubTator, text mining | PubMed |
| Comprehensive pan-cancer analysis reveals NUSAP1 is a novel predictive biomarker for prognosis and immunotherapy response. | Int J Biol Sci | 2023 | 37781040 | PubTator, text mining | PubMed |
| New Challenges for Anatomists in the Era of Omics. | Diagnostics (Basel) | 2023 | 37761332 | PubTator, text mining | PubMed |
| Role of NFE2L1 in the Regulation of Proteostasis: Implications for Aging and Neurodegenerative Diseases. | Biology (Basel) | 2023 | 37759569 | PubTator, text mining | PubMed |
| Biochemical and Molecular Pathways in Neurodegenerative Diseases: An Integrated View. | Cells | 2023 | 37759540 | PubTator, text mining | PubMed |
| Blood-Based Biomarkers for Neuroprognostication in Acute Brain Injury. | Semin Neurol | 2023 | 37751855 | PubTator, text mining | PubMed |
| Pervasive mislocalization of pathogenic coding variants underlying human disorders. | bioRxiv | 2023 | 37732209 | PubTator, text mining | PubMed |
| Cancer-specific association between Tau (MAPT) and cellular pathways, clinical outcome, and drug response. | Sci Data | 2023 | 37730697 | PubTator, text mining | PubMed |
| Secondary neurodegeneration following Stroke: what can blood biomarkers tell us? | Front Neurol | 2023 | 37719764 | PubTator, text mining | PubMed |
| Upregulated SPAG6 correlates with increased STAT1 and is associated with reduced sensitivity of interferon-α response in BCR::ABL1 negative myeloproliferative neoplasms. | Cancer Sci | 2023 | 37681349 | PubTator, text mining | PubMed |
Long-term administration of intravenous Trappsol® Cyclo™ (HP-β-CD) results in clinical benefits and stabilization or slowing of disease progression in patients with Niemann-Pick disease type C1: Results of an international 48-week Phase I/II trial. | Mol Genet Metab Rep | 2023 | 37670901 | PubTator, text mining | PubMed |
| Immunological characterization and diagnostic models of RNA N6-methyladenosine regulators in Alzheimer's disease. | Sci Rep | 2023 | 37666846 | PubTator, text mining | PubMed |
| Plasma phosphorylated tau181 as a biomarker of mild traumatic brain injury: findings from THINC and NCAA-DoD CARE Consortium prospective cohorts. | Front Neurol | 2023 | 37662031 | PubTator, text mining | PubMed |
| Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants With Mild-to-Moderate Alzheimer Disease: Lauriet. | Neurology | 2023 | 37643887 | PubTator, text mining | PubMed |
| Multiancestry analysis of the HLA locus in Alzheimer's and Parkinson's diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes. | Proc Natl Acad Sci U S A | 2023 | 37643212 | PubTator, text mining | PubMed |
| Exploring the role of COX-2 in Alzheimer's disease: Potential therapeutic implications of COX-2 inhibitors. | Saudi Pharm J | 2023 | 37638222 | PubTator, text mining | PubMed |
| The mechanisms related to fibroblasts in burn surface. | Skin Res Technol | 2023 | 37632175 | PubTator, text mining | PubMed |
| The Role of Novel Imaging and Biofluid Biomarkers in Traumatic Axonal Injury: An Updated Review. | Biomedicines | 2023 | 37626808 | PubTator, text mining | PubMed |
| Using Stems to Bear Fruit: Deciphering the Role of Alzheimer's Disease Risk Loci in Human-Induced Pluripotent Stem Cell-Derived Microglia. | Biomedicines | 2023 | 37626736 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51115/papers?page=15